A new ITAL-neo registry study reveals a threefold reduction in moderate or greater paravalvular leak (PVL) with the second-generation ACURATE neo2 valve compared with its predecessor, ACURATE neo.
The primary endpoint of moderate or greater PVL on predischarge echocardiography occurred in 3. 5% patients with the ACURATE neo2 vs 11
